Results 31 to 40 of about 624 (119)
Cell Reports, 2017 Here, we present a large (n = 107,207) genome-wide association study (GWAS) of general cognitive ability (“g”), further enhanced by combining results with a large-scale GWAS of educational attainment.
Max Lam +64 more
doaj +1 more source
Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction
Pharmaceutics, 2021 Late-life mild cognitive impairment and dementia represent a significant burden on healthcare systems and a unique challenge to medicine due to the currently limited treatment options.
Maria D. Auxtero +4 more
doaj +1 more source
The use of nootropics in Alzheimer’s disease: is there light at the end of the tunnel? [PDF]
, 2019 Background: The nootropic or simply known as smart drug is a common term given to any compound that is responsible for enhancing mental capability or performance.
Amom, Zulkhairi +5 more
core +1 more source
Socio-anthropologie, 2021 This article aims at questioning the promise of cognitive optimization based on the promotion of substances classified as “nootropics”. This paper focuses on the circulation of this promise and the products that support it, as well as on contemporary ...
Félix Denis
doaj +1 more source
Cognitive enhancers derived from edible crops [PDF]
, 2020 The concept of an effective cognitive boosting nootropic supplement is gaining traction with consumers, neuroscientists and regulators alike and it is therefore unsurprising that scientifically validated Nootropics are highly prized.
Chapman, Natalie, Fisk, Ian
core +5 more sources
Food for thought: Dietary nootropics for the optimisation of military operators cognitive performance [PDF]
Nootropics are compounds that enhance cognitive performance and have been highlighted as a medium-term human augmentation technology that could support soldier performance. Given the differing ethical, safety, and legal considerations associated with the
Blacker, Sam D. +2 more
core +2 more sources
Nootropics in a Complex Therapy of Chronic Cerebral Ischemia [PDF]
, 2014 Изложена клинико-фармакологическая характеристика ноотропов – одной из наиболее продуктивных групп нейропсихотропных лекарственных препаратов. Построена классификация ноотропных средств по основному механизму действия.
Горчакова, Н.А. +6 more
core +1 more source
Plant-derived nootropics and human cognition: A systematic review
, 2022 Substances with modulatory capabilities on certain aspects of human cognition have been revered as nootropics from the dawn of time. The plant kingdom provides most of the currently available nootropics of natural origin. Here, in this systematic review,
María Mulet (11895354) +10 more
core +1 more source
A Drug Utilization Study of Cognition Enhancers in Dementia in a Tertiary Care Hospital in Mumbai [PDF]
Journal of Clinical and Diagnostic Research, 2014 Background: Cognitive decline is one of the important factors undermining the quality of life in geriatric patients. Although the WHO has declared ‘Dementia’ as a priority health condition. Cognitive neuropharmacology is still in its infancy and there
Karan Thakkar +2 more
doaj +1 more source
Cognitive-enhancing drugs in the healthy population: Fundamental drawbacks and researcher roles
Cogent Psychology, 2015 The use of pharmacological cognitive enhancers (PCEs) in the healthy population is a controversial topic with numerous and expansive repercussions. By outlining common proponent arguments on the current PCE state of affairs, the definition of normality ...
Tsee Leng Choy
doaj +1 more source